The most common form of hereditary deafness in humans is caused by mutations in the GJB2 gene, which encodes the gap junction protein connexin 26. That regulates the transport of potassium and ...

Sensorion receives DMC recommendation to continue the Audiogene phase 1/2 trial of SENS-501: Montpellier, France Monday, February 24, 2025, 18:00 Hrs [IST] Sensorion, a pioneering ...

Sensorion's Audiogene Phase I/II trial of the SENS-501 gene therapy programme has received a favourable recommendation from ...

Breaking this down by channel, U.S. retail net revenues increased 5.7% to $33.9 million in the fourth quarter of 2024 compared to $32.1 million in the year ago period, primarily due to a 10.6% ...

Ten children who received DB-OTO for profound genetic hearing loss due to variants of the otoferlin gene showed notable ...

Learn about the causes of age-related hearing loss and discover effective strategies to manage presbycusis. Early ...

Regeneron’s gene therapy, dubbed DB-OTO, is a cell-selective AAV gene therapy for children with hearing loss stemming from a ...

Regeneron's DB-OTO gene therapy shows improved hearing in 10 of 11 children in the CHORD trial, with three reaching ...

The brain may play a role in helping the ear regulate its sensitivity to sound and compensate for hearing loss by sending a ...

As the Blue Jackets celebrate Hockey Is For Everyone Night, the 11-year-old in the Blue Jackets Hockey League is an example ...